# Cerebral Autoregulation and COVID-19

> **NCT04930874** · NA · TERMINATED · sponsor: **University of Athens** · enrollment: 7 (actual)

## Conditions studied

- COVID-19 Acute Respiratory Distress Syndrome
- COVID-19 Pneumonia

## Interventions

- **OTHER:** NIRS (Near-Infrared Spectroscopy)

## Key facts

- **NCT ID:** NCT04930874
- **Lead sponsor:** University of Athens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-06-22
- **Primary completion:** 2022-09-16
- **Final completion:** 2022-09-16
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Low rate of enrollment
- **Last updated:** 2024-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930874, "Cerebral Autoregulation and COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04930874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*